Monitoring
Long-term monitoring by a consultant multidisciplinary team is advised; visits at least on a 6-monthly basis for patients receiving treatment, or annually for patients on observation. Genetic counselling, carrier detection, screening of family members may all need to be undertaken.
Use of this content is subject to our disclaimer